Title:
Equipment Investment for collaborative R&D in automated mammalian cell line genomics at Concordia University
Agreement Value:
$2,398,562.00
Agreement Date:
Sep 15, 2018 - Dec 31, 2020
Description:
Procurement, installation, commissioning and protocol development for equipment to form an automated mammalian cell line genomics platform at Concordia University's Genome Foundry enabling high throughput cell growth, transfection and selection, automation build out and enhanced sequencing capacity.
Organization:
National Research Council Canada
Expected Results:
In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.
Location:
Montreal, Quebec, CA H3G 1M8
Reference Number:
172-2019-2020-Q4-924026
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
106966591
Additional Information:
This agreement has been amended 2 time(s). The end date of this agreements has been modified by 275 days. The total amended value is 2,398,562 dollars.
Amendment Date
May 6, 2020
Recipient's Legal Name:
Concordia University
Federal Riding Name:
Ville-Marie–Le Sud-Ouest–Île-des-Sœurs
Federal Riding Number:
24077
Program:
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Program Purpose:
Collaborate on multiparty research and development programs to catalyze transformative, high-risk, high-reward research with the potential for game-changing scientific discoveries and technological breakthroughs in priority areas.
NAICS Code:
541710 - R&D in the physical, engineering and life sciences